This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Tenet Healthcare (THC) Beats on Q2 Earnings, Ups '21 EPS View
by Zacks Equity Research
Tenet Healthcare's (THC) second-quarter results gain on the back of higher revenues, and well-performing Hospital, Ambulatory and Conifer segments, partly offset by escalating costs.
Anthem's (ANTM) Q2 Earnings Beat Estimates, Decline Y/Y
by Zacks Equity Research
Anthem's (ANTM) Q2 earnings gain from better revenues and growth in Medicaid and Medicare business lines.
HCA Healthcare's (HCA) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
HCA Healthcare's (HCA) Q2 earnings gain traction from higher revenues and improved admissions.
Has UnitedHealth Group (UNH) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (UNH) Outperforming Other Medical Stocks This Year?
Bear of the Day: Vericel (VCEL)
by Kevin Cook
Restoring cartilage in sports medicine and rebuilding skin after severe burns gave this small-cap big upside
UnitedHealth's Solid Q2 Earnings Put These ETFs in Focus
by Sweta Killa
UnitedHealth reported better-than-expected second-quarter 2021 results, breezing past the Zacks Consensus Estimate for both earnings and revenues.
Company News for Jul 16, 2021
by Zacks Equity Research
Companies In The News Are: UNH, MS, USB, TFC
Economic and Earnings Data Deluge
by Zacks Equity Research
Economic and Earnings Data Deluge
Smorgasbord of Econ Data, Q2 Earnings
by Mark Vickery
Jobless claims, manufacturing reports, import/exports and fresh Q2 earnings releases dominate the morning's headlines.
UnitedHealth (UNH) Beats on Q2 Earnings, Hikes '21 EPS View
by Zacks Equity Research
UnitedHealth Group's (UNH) second-quarter 2021 results reflect improving revenues resulting in top-line growth at both the business units, partly offset by higher costs.
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
UnitedHealth Group (UNH) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
UnitedHealth (UNH) delivered earnings and revenue surprises of 6.58% and 3.04%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Mixed Close on Q2 Earnings, Powell Testimony
by Mark Vickery
Investors are growing a little nervous that continued inaction to combat inflation will allow it to take over the U.S. economy.
5 Earnings Charts to Kick off Earnings Season
by Tracey Ryniec
Investors should be watching more than just the big banks this week.
Can UnitedHealth (UNH) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
UnitedHealth (UNH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Should You Add Anthem (ANTM) Stock to Your Portfolio?
by Zacks Equity Research
Aided by high revenues and strong Medicaid and Medicare businesses, Anthem (ANTM) holds enough potential to reap benefits for investors.
Dow ETF Set to Rise Further as Q2 Earnings Kick Off
by Sweta Killa
With some blue-chip companies' earnings scheduled for the coming days, investors should closely monitor the movement of the Dow ETF and grab an opportunity that arises from a surge in any of the 30 stocks.
Why This 1 Medical Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
The Zacks Analyst Blog Highlights: Apple, UnitedHealth Group, Bank of America, Morgan Stanley and Applied Materials
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Apple, UnitedHealth Group, Bank of America, Morgan Stanley and Applied Materials
Top Research Reports for Apple, UnitedHealth & Bank of America
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Apple (AAPL), UnitedHealth Group (UNH), and Bank of America (BAC).
Humana (HUM) Joins Montefiore Health for Better Healthcare
by Zacks Equity Research
Humana (HUM) inks a deal with Montefiore Health System to better serve Humana Medicare Advantage members in Bronx, Westchester and Hudson Valley.
UnitedHealth (UNH) to Post Q2 Earnings: What's in the Offing?
by Zacks Equity Research
UnitedHealth's (UNH) Q2 revenues are likely to have grown on higher membership. Nevertheless, COVID-related costs and steep expenses due to investment in growth and innovation might have hurt earnings.
Ah Yes! Q2 Earnings Season: Global Week Ahead
by John Blank
A big part of the unusually strong earnings growth expected in the Q2 earnings season is due to easy comparisons to last year. But not all of the growth is a result of easy comparisons.
Markets Await Earnings and Economic Data
by Zacks Equity Research
Markets Await Earnings and Economic Data